Analysts Estimates and Ratings Marinus Pharmaceuticals, Inc.(NASDAQ:MRNS): Neuralstem, Inc.(NASDAQ:CUR)

0
7

Marinus Pharmaceuticals, Inc. (MRNS) will report its next earnings on May 01. The company reported the earnings of $-0.24/Share in the last quarter where the estimated EPS by analysts was $-0.21/share. The difference between the expected and actual EPS was $-0.03/share, which represents an Earnings surprise of -14.3%.

Many analysts are providing their Estimated Earnings analysis for Marinus Pharmaceuticals, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $-0.24/share. These analysts have also projected a Low Estimate of $-0.27/share and a High Estimate of $-0.2/share.

These analysts also forecasted Growth Estimates for the Current Quarter for MRNS to be 4.2%. They are projecting Next Quarter growth of 18.52%. For the next 5 years, Marinus Pharmaceuticals, Inc. is expecting Growth of -1.78% per annum, whereas in the past 5 years the growth was 0% per annum.

Some buy side analysts are also providing their Analysis on Marinus Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Marinus Pharmaceuticals, Inc. might touch $24.5 high while the Average Price Target and Low price Target is $16.06 and $5 respectively.

Marinus Pharmaceuticals, Inc. closed its last trading session at $4.47 with the gain of 3.13%. The Market Capitalization of the company stands at 241.79 Million. The Company has 52-week high of $10.54 and 52-week low of $2.36. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.87% where SMA50 and SMA200 are 9.41% and -6.65% respectively. The Company Touched its 52-Week High on 10/01/18 and 52-Week Low on 12/21/18.

The Relative Volume of the company is 0.43 and Average Volume (3 months) is 753.3 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -74%. The Return on Equity (ROE) value stands at -83.8%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Marinus Pharmaceuticals, Inc. currently shows a Weekly Performance of -2.74%, where Monthly Performance is 10.55%, Quarterly performance is 30.97%, 6 Months performance is -13.51% and yearly performance percentage is -4.16%. Year to Date performance value (YTD perf) value is 60.63%. The Stock currently has a Weekly Volatility of 5.81% and Monthly Volatility of 8.34%.

Neuralstem, Inc. (CUR) will report its next earnings on Jun 21 BMO. The company reported the earnings of $-0.36/Share in the last quarter where the estimated EPS by analysts was $-0.73/share. The difference between the expected and actual EPS was $0.37/share, which represents an Earnings surprise of 50.7%.

Many analysts are providing their Estimated Earnings analysis for Neuralstem, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Neuralstem, Inc. closed its last trading session at $0.43 with the gain of 9.81%. The Market Capitalization of the company stands at 9.81 Million. The Company has 52-week high of $1.78 and 52-week low of $0.25. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -2.93% where SMA50 and SMA200 are -3.78% and -30.08% respectively. The Company Touched its 52-Week High on 06/04/18 and 52-Week Low on 01/15/19.

The Relative Volume of the company is 0.42 and Average Volume (3 months) is 257.64 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -54.4%. The Return on Equity (ROE) value stands at -84.6%. While it’s Return on Investment (ROI) value is -137.7%.

While looking at the Stock’s Performance, Neuralstem, Inc. currently shows a Weekly Performance of -9.04%, where Monthly Performance is 10.69%, Quarterly performance is 11.64%, 6 Months performance is -15.68% and yearly performance percentage is -72.67%. Year to Date performance value (YTD perf) value is 50.11%. The Stock currently has a Weekly Volatility of 15.90% and Monthly Volatility of 14.41%.

SHARE